Epinique is a science-driven medical device company developing a novel wound-dressing material designed to accelerate recovery, improve patient outcomes, and reduce the overall cost of care. Our approach integrates deep expertise in biomaterials, medical devices, and product development to advance next-generation wound-care solutions that deliver measurable impact.

Our proprietary dressing material is engineered to enhance healing performance and promote faster tissue recovery, enabling clinicians to shorten treatment timelines and patients to regain quality of life sooner. By focusing on materials that combine functionality, comfort, and manufacturability, we aim to redefine what wound dressings can achieve in both acute and chronic care settings.

Currently in the research stage, Epinique is progressing toward pilot manufacturing to prepare for preclinical validation and early market readiness.

Our multidisciplinary team brings decades of experience in medical devices, biomaterials, regulatory pathways, and global commercialization, with a proven record of translating innovation from concept to market. Headquartered in Switzerland and shaped by international expertise across Europe, Asia, the US, the UK, and Latin America, Epinique unites scientific rigor with practical execution to deliver solutions that matter — to patients, clinicians, and partners worldwide.

Epinique AG

Org chart

Teams

Offices